As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).
Atrial Fibrillation Market report categorizes the global market by Product (EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure), End User & Geography
As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).
The development of biomaterials has improved the diagnosis, treatment, and monitoring of injury and illness significantly. In addition, continuing advances in medical software design now allow surgeons to use accurate models to assist them in preparing for increasingly complex surgeries. The invention of novel biomaterials, therefore, relies on multi-disciplinary innovation and imagination. Such developments offer greater hope for patients and may have far-reaching implications on the growth of the biomaterials market, globally.
According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market
The Left Atrial Appendage Market size is estimated to reach $2,247 million by 2027. Furthermore, it is poised to grow at a CAGR of 19.7% over the forecast period of 2022-2027. The left arterial appendage is a small ear-shaped sac found in the muscle wall of the left atrium. When a person isn’t suffering from any major ailments, the blood in the left atrium and LAA is squeezed out of the left atrium into the left ventricle (bottom left chamber of the heart) as and when the heart contracts or beat. However, in cases of atrial fibrillation, the electrical impulses which guide the heart to beat do not follow the right motion or order.
According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market
According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market
The global emulsifiers market size is expected to reach USD 13.08 Billion at a revenue CAGR of 6.3% in 2028, according to latest analysis by Emergen Research. Rapidly rising demand for convenience and processed foods, increasing oil and gas exploration and production activities, and increasing food demand globally are some key factors driving steady market revenue growth.
Research Beam added a report on “Atrial Fibrillation - Pipeline Review, H2 2015” Enquiry about report: http://www.researchbeam.com/atrial-fibrillation-pipeline-review-h2-2015-market/enquire-about-report
Germany held dominant position in Europe gelatin and bone glue market in 2019, accounting for 23.5% share in terms of volume, followed by France and U.K.,respectively
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market.
Download Sample Brochure @ http://bit.ly/2e5cuFZ The increase in the adoption of advanced technologies in enterprises landscape has been increasing the workloads. Balancing the workload and reducing the operational cost have become the key elements for the enterprises to achieve the greater revenue and meet the customer needs. The adoption of cloud automation in industry verticals will help to improve the operational activities, reduce the operational costs, improve business agility, and improve the productivity. Read Analysis @ http://bit.ly/2dNdn2C
Market reports on India presents the latest report on “Medical Lifting Sling Market by Country Forecast 2015 - 2021” http://www.maretreportsonindia.com/life-sciences-market-research-reports-13468/kmedical-lifting-sling.html The key driver for this market is the increasing number of people suffering from atrial fibrillation.
Big Market Research “Global Heparin Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-heparin-2015-2019-market Heparin is an anticoagulant or blood thinner produced by basophils and mast cells. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to function and dissolve clots. A porcine intestine or bovine lungs extract of heparin is used pharmaceutically in conditions such as DVT, pulmonary embolism, acute coronary syndrome, and atrial fibrillation to prevent clots. It is also used during surgeries to prevent clot formation.
Asia Pacific Electrophysiology (EP) Market Size is estimated to cross USD 2.5 Billion By 2027. Increasing prevalence of cardiac disorders such as atrial fibrillation, atrial flutter and tachycardia among others in the region and launch of new advanced products will influence electrophysiology revenue growth during forecast period. The recent COVID-19 pandemic has negatively impacted the electrophysiology procedures upto some extent. Elective procedures were differed during the initial phase of the outbreak to reduce cross contamination in healthcare settings. However, as COVID-19 cases are declining across the globe, the APAC electrophysiology market will witness gradual growth in the future.
Big Market Research, EpiCast Report: Atrial Fibrillation Epidemiology Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, to 2023. Atrial fibrillation (AF) is a disorder of the heart’s electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide. According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world''s population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population, especially the elderly population.
Thrombosis drugs are defined as the drugs that inhibit the function of platelets to prevent the formation of clots and inhibit the formation of new clots. These drugs help to prevent conditions such as arterial fibrillation and deep vein thrombosis. These drugs may cause side effects such as bleeding, vomiting, heavy menstrual periods and bleeding from gums and nose. Thrombotic treatment is used to cure or to dissolve the clots to prevent blockage of specific organ and the drugs which are used in thrombotic are called blood thinners; for instance, heparin and warfarin.
The Electrophysiology Market is expected to witness significant growth by 2032, driven by the rising prevalence of lifestyle-related health conditions. Sedentary habits, excessive alcohol consumption, and smoking have led to a marked increase in heart disease cases, further boosting the demand for electrophysiology (EP) tests.
An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.
The Dental Laser Market is projected to witness substantial growth from 2023 to 2032, driven by the rising prevalence of oral diseases globally. Additionally, the increasing demand for minimally invasive procedures has fueled the adoption of dental lasers, as they provide a less painful and faster alternative to traditional treatments.
The global heparin market is anticipated to witness growth with a CAGR of 4.01% during the forecast period, 2024 to 2032. Read More about our press releases.
Strong prevalence and growth in number of patients suffering from cardiovascular diseases, increasing number of hip and knee replacement surgical procedures, growth in atrial fibrillation, and increasing incidences of deep vein thrombosis (DVT) are the key factors fueling growth of the global anticoagulant market. Anticoagulants are used to prevent formation of blood clots by reacting with the clotting chemicals in the blood
The global ablation technology market size is expected to reach USD 13.87 Billion in 2032 and register a steady revenue CAGR of 9.3% during the forecast period, according to latest analysis by Emergen Research. Increasing development of advanced technologies and rising availability and accessibility of innovative ablation products are major factors driving market revenue growth.
Market Size – USD 904.5 Million in 2021, Market Growth – at a CAGR of 7.0%, Market Trends – Growing Research & Development (R&D) activities in the North America region
Global Implantable Loop Recorders Market was valued $469.0 Million in 2018, and is projected to reach $813.5 Million by 2025; with a CAGR of 8.4% from 2019 to 2025.
The global cardiovascular pharmaceuticals market is estimated to garner a revenue of USD 234 Billion by the end of 2033 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2033.
According to the latest research report by IMARC Group, The global anticoagulants market size reached US$ 37.4 Billion in 2022 Looking forward, IMARC Group expects the market to reach US$ 67.0 Billion by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028. More Info:- https://www.imarcgroup.com/anticoagulants-market
The global fabric protection market size was USD 2.42 Billion in 2022 and is expected to reach USD 4.7 Billion in 2032, and register a revenue CAGR of 7.6% during the forecast period. Rising demand for hassle-free apparel that is easy to clean and maintain and fabric protection products in recreational activities and adventurous sports Clothing, along with increasing awareness about the harmful effects of chemicals on the environment and human health are major factors driving market revenue growth.
The global pacemaker market is likely to post a CAGR of 6.5% over the forecast period of 2018-2023, asserts Market Research Future (MRFR) in an exclusive study.
The global electrophysiology market is on the path to generating $17,482.7 million by 2030, compared to $7,076.1 million in 2021, advancing at a compound annual growth rate of 10.6% between 2021 and 2030. The growing count of cardiac ablation procedures, rising reforms for healthcare infrastructure growth, increasing demand for ablation and diagnostic catheters, and technology advancements are some major aspects driving the growth of the market.
According to the latest research report by IMARC Group, The global ablation devices market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. More Info:- https://www.imarcgroup.com/ablation-devices-market
The global home healthcare market size was USD 198.78 Billion in 2021 and is expected to register a revenue CAGR of 8.3%, during the forecast period, according to the latest analysis by Emergen Research. Home healthcare market revenue growth is primarily driven by factors such as rising incidence of chronic diseases such as diabetes, cardiovascular disease, and hypertension and increasing technological advancements in-home healthcare products.
Looking forward, the anticoagulants market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/anticoagulants-market
North America Electrophysiology Market Size is Estimated To Exceed USD 3.5 Billion By 2027.Novel product launch and growing incidence of several cardiac arrhythmias is set to gradually stimulate electrophysiology market growth. The COVID-19 pandemic has significantly disrupted the healthcare industry up to great extent. It has impacted the business sales of several firms and subsequently the revenue generated through elective and non-emergent procedures. With such impact, the number of electrophysiology procedures conducted in 2020 witnessed considerable downfall and has thereby negatively influenced the overall North America electrophysiology market size. However, with growing incidence of heart rhythm disorders and subsequent deterioration in prevalence of coronavirus infection, the industry is forecasted to recover and gradually grow in the foreseeable future to meet the unmet market demand.
The global optically clear adhesives market size is expected to reach USD 3,218.7 Million in 2028 and register a revenue CAGR of 9.2% over the forecast period, according to latest analysis by Emergen Research. Some key factors driving steady market revenue growth include rising demand for touchscreen display devices and optical devices among consumers.
Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH.... @ @ https://bit.ly/3xswTsQ
The global endometrial ablation devices market size is expected to reach USD 1,596.9 Million at a steady revenue CAGR of 5.3% in 2028, according to latest analysis by Emergen Research. Steady endometrial ablation devices market revenue growth can be attributed to rising prevalence of gynecological disorders in women, including menorrhagia that are responsible for patients opting for advanced surgical procedures such as endometrial ablation.
TBRC global electrophysiology devices and equipment market report includes electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology lab systems https://bit.ly/3l7ZKzo